| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 520 | $1,250 | $650.4K |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 550 | $440 | $242.7K |
| 78816 | The patient is injected with a radiopharmaceutical tracer called FDG (fluoro–deoxyglucose, a radioactive substance containing glucose) about one hour before the imaging is scheduled to begin. The… | 90 | $1,240 | $110.5K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 430 | $90 | $38.7K |
| 78830 | The provider uses a nuclear imaging test called SPECT with concurrent CT imaging to localize a tumor, inflammatory process, or radioactive tracer distribution. Vascular flow and blood pool imaging… | 160 | $60 | $9.7K |
| 77080 | The provider performs an imaging procedure, called dual–energy X–ray absorptiometry (DXA), of one or more bony areas on the trunk to determine the bone mineral density (BMD) and whether the patient… | 320 | $20 | $7.1K |
| 78452 | In this procedure, the provider performs multiple SPECT studies of the heart to determine the areas of deficient blood flow. The goal of the procedure is to determine areas that have deficient blood… | 90 | $70 | $5.9K |
| 78195 | In this procedure, the provider uses a gamma–emitting radioactive tracer to diagnose and localize diseases of the lymphatics and lymph nodes. | 50 | $50 | $2.3K |
| 78597 | In this diagnostic procedure, the provider performs pulmonary perfusion, a nuclear scan test that evaluates the flow of blood within the patient’s lungs. The aim is to perform quantitative analysis… | 70 | $30 | $2.2K |
| 78580 | In this diagnostic procedure, the provider performs a nuclear perfusion imaging test to evaluate the circulation of blood within the patient’s lungs. He does this to identify the presence of any… | 50 | $30 | $1.6K |